BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Rudy Li does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 PRTAProthena Corporation plc | Buy | $18.00 | May 2025 | +102.9% | Miss |
| PRTAProthena Corporation plc | Buy | $40.00 | May 2025 | +20.0% | Miss |
 CNTACentessa Pharmaceuticals PLC ADR | Buy | $30.00 | May 2025 | +211.8% | Hit |
 STOKStoke Therapeutics Inc | Buy | $24.00 | Mar 2025 | +297.0% | Hit |
| PRTAProthena Corporation plc | Buy | $40.00 | Feb 2025 | −49.7% | Miss |
| STOKStoke Therapeutics Inc | Buy | $24.00 | Feb 2025 | +284.6% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.